BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12801918)

  • 1. Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle.
    Keira Y; Noguchi S; Minami N; Hayashi YK; Nishino I
    J Biochem; 2003 May; 133(5):659-64. PubMed ID: 12801918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle-specific calpain, p94, and connectin/titin: their physiological functions and relationship to limb-girdle muscular dystrophy type 2A.
    Sorimachi H; Ono Y; Suzuki K
    Adv Exp Med Biol; 2000; 481():383-95; discussion 395-7. PubMed ID: 10987085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence.
    Sorimachi H; Kinbara K; Kimura S; Takahashi M; Ishiura S; Sasagawa N; Sorimachi N; Shimada H; Tagawa K; Maruyama K
    J Biol Chem; 1995 Dec; 270(52):31158-62. PubMed ID: 8537379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A.
    Vainzof M; de Paula F; Tsanaclis AM; Zatz M
    J Clin Pathol; 2003 Aug; 56(8):624-6. PubMed ID: 12890817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle.
    Baghdiguian S; Richard I; Martin M; Coopman P; Beckmann JS; Mangeat P; Lefranc G
    J Mol Med (Berl); 2001 Jun; 79(5-6):254-61. PubMed ID: 11485017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain.
    Jia Z; Petrounevitch V; Wong A; Moldoveanu T; Davies PL; Elce JS; Beckmann JS
    Biophys J; 2001 Jun; 80(6):2590-6. PubMed ID: 11371436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocation of molecular chaperones to the titin springs is common in skeletal myopathy patients and affects sarcomere function.
    Unger A; Beckendorf L; Böhme P; Kley R; von Frieling-Salewsky M; Lochmüller H; Schröder R; Fürst DO; Vorgerd M; Linke WA
    Acta Neuropathol Commun; 2017 Sep; 5(1):72. PubMed ID: 28915917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible functions of p94 in connectin-mediated signaling pathways in skeletal muscle cells.
    Ojima K; Ono Y; Hata S; Koyama S; Doi N; Sorimachi H
    J Muscle Res Cell Motil; 2005; 26(6-8):409-17. PubMed ID: 16453164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myogenic stage, sarcomere length, and protease activity modulate localization of muscle-specific calpain.
    Ojima K; Ono Y; Doi N; Yoshioka K; Kawabata Y; Labeit S; Sorimachi H
    J Biol Chem; 2007 May; 282(19):14493-504. PubMed ID: 17371879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myopathy phenotype of transgenic mice expressing active site-mutated inactive p94 skeletal muscle-specific calpain, the gene product responsible for limb girdle muscular dystrophy type 2A.
    Tagawa K; Taya C; Hayashi Y; Nakagawa M; Ono Y; Fukuda R; Karasuyama H; Toyama-Sorimachi N; Katsui Y; Hata S; Ishiura S; Nonaka I; Seyama Y; Arahata K; Yonekawa H; Sorimachi H; Suzuki K
    Hum Mol Genet; 2000 May; 9(9):1393-402. PubMed ID: 10814721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice.
    Richard I; Roudaut C; Marchand S; Baghdiguian S; Herasse M; Stockholm D; Ono Y; Suel L; Bourg N; Sorimachi H; Lefranc G; Fardeau M; Sébille A; Beckmann JS
    J Cell Biol; 2000 Dec; 151(7):1583-90. PubMed ID: 11134085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A.
    Ono Y; Shimada H; Sorimachi H; Richard I; Saido TC; Beckmann JS; Ishiura S; Suzuki K
    J Biol Chem; 1998 Jul; 273(27):17073-8. PubMed ID: 9642272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A.
    Anderson LV; Davison K; Moss JA; Richard I; Fardeau M; Tomé FM; Hübner C; Lasa A; Colomer J; Beckmann JS
    Am J Pathol; 1998 Oct; 153(4):1169-79. PubMed ID: 9777948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures.
    Mercuri E; Bushby K; Ricci E; Birchall D; Pane M; Kinali M; Allsop J; Nigro V; Sáenz A; Nascimbeni A; Fulizio L; Angelini C; Muntoni F
    Neuromuscul Disord; 2005 Feb; 15(2):164-71. PubMed ID: 15694138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aspect of the research on limb-girdle muscular dystrophy 2A: a molecular biologic and biochemical approach to pathology.
    Ono Y; Sorimachi H; Suzuki K
    Trends Cardiovasc Med; 1999 Jul; 9(5):114-8. PubMed ID: 10639725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of calpain 3 in a form of limb-girdle muscular dystrophy (LGMD2A).
    Spencer MJ; Tidball JG; Anderson LV; Bushby KM; Harris JB; Passos-Bueno MR; Somer H; Vainzof M; Zatz M
    J Neurol Sci; 1997 Mar; 146(2):173-8. PubMed ID: 9077514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression.
    Fanin M; Nascimbeni AC; Fulizio L; Trevisan CP; Meznaric-Petrusa M; Angelini C
    Am J Pathol; 2003 Nov; 163(5):1929-36. PubMed ID: 14578192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle-specific calpain-3 is phosphorylated in its unique insertion region for enrichment in a myofibril fraction.
    Ojima K; Ono Y; Hata S; Noguchi S; Nishino I; Sorimachi H
    Genes Cells; 2014 Nov; 19(11):830-41. PubMed ID: 25252031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, pathological, and genetic features of limb-girdle muscular dystrophy type 2A with new calpain 3 gene mutations in seven patients from three Japanese families.
    Kawai H; Akaike M; Kunishige M; Inui T; Adachi K; Kimura C; Kawajiri M; Nishida Y; Endo I; Kashiwagi S; Nishino H; Fujiwara T; Okuno S; Roudaut C; Richard I; Beckmann JS; Miyoshi K; Matsumoto T
    Muscle Nerve; 1998 Nov; 21(11):1493-501. PubMed ID: 9771675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A.
    Baghdiguian S; Martin M; Richard I; Pons F; Astier C; Bourg N; Hay RT; Chemaly R; Halaby G; Loiselet J; Anderson LV; Lopez de Munain A; Fardeau M; Mangeat P; Beckmann JS; Lefranc G
    Nat Med; 1999 May; 5(5):503-11. PubMed ID: 10229226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.